Global Venous thromboembolism(VTE)Therapeutics Market Insights, Forecast to 2025

SKU ID : QYR- 13467700

Publishing Date : 16-May-2019

No. of pages : 117

PRICE
4900
9800


  • Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE 
    One of the Major drivers of VTE market growth over the forecast period is the increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.
    The global Venous thromboembolism(VTE)Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Venous thromboembolism(VTE)Therapeutics market based on company, product type, end user and key regions.

    This report studies the global market size of Venous thromboembolism(VTE)Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Venous thromboembolism(VTE)Therapeutics in these regions.
    This research report categorizes the global Venous thromboembolism(VTE)Therapeutics market by top players/brands, region, type and end user. This report also studies the global Venous thromboembolism(VTE)Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

    The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Boehringer Ingelheim
    Bayer
    Janssen
    Bristol-Myers Squibb
    Pfizer
    Daiichi-Sankyo
    Portola Pharmaceuticals
    Armetheon

    Market size by Product
    Deep Vein Thrombosis(DVT)
    Pulmonary Embolism(PE)
    Others
    Market size by End User
    Hospital
    ASCs
    Research Institutes

    Market size by Region
    North America
    United States
    Canada
    Mexico
    Asia-Pacific
    China
    India
    Japan
    South Korea
    Australia
    Indonesia
    Singapore
    Malaysia
    Philippines
    Thailand
    Vietnam
    Europe
    Germany
    France
    UK
    Italy
    Spain
    Russia
    Central & South America
    Brazil
    Rest of Central & South America
    Middle East & Africa
    GCC Countries
    Turkey
    Egypt
    South Africa

    The study objectives of this report are:
    To study and analyze the global Venous thromboembolism(VTE)Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Venous thromboembolism(VTE)Therapeutics market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Venous thromboembolism(VTE)Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Venous thromboembolism(VTE)Therapeutics submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    In this study, the years considered to estimate the market size of Venous thromboembolism(VTE)Therapeutics are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

    This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Venous thromboembolism(VTE)Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.